Pfizer Inc. is vulnerable to the possibility that President Donald Trump will place tariffs on the European Union, where the ...
We recently published a list of 10 Best Very Cheap Stocks To Buy Right Now. In this article, we are going to take a look at ...
We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...
Pfizer Inc. closed 19.06% short of its 52-week high of $31.54, which the company reached on July 30th.
All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...
Pfizer Inc (PFE) reports robust financial performance with significant revenue growth and strategic progress in oncology and ...
Pfizer clinches the top spot in the competitive 2025 Super Bowl ad race, promising groundbreaking visibility during the big ...
Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...
Pfizer faces stagnant revenue and patent cliffs. Learn why I downgraded PFE stock to Strong Sell despite a 24.7% YoY growth ...
Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results